Finance

Lists
Why is INKT down 2,55%?
Dive Deeper
INKT:NASDAQ
Mink Therapeutics Inc
10,72 US$
-2,55%
(-0,28) 1D
11,01 US$
+2,71% (+0,29)
After hours
Closed: 9 ოქტ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INKT...
Open
10,96 US$
High
10,96 US$
Low
10,68 US$
Mkt. cap
54,70 მლნ.
Avg. vol.
18,22 ათ.
Volume
16,98 ათ.
52-wk high
16,93 US$
52-wk low
8,48 US$
EPS
-2,40 US$
Beta
0,47
Shares outstanding
5,10 მლნ.
No. of employees
15
Open
10,96 US$
High
10,96 US$
Low
10,68 US$
Mkt. cap
54,70 მლნ.
Avg. vol.
18,22 ათ.
Volume
16,98 ათ.
52-wk high
16,93 US$
52-wk low
8,48 US$
EPS
-2,40 US$
Beta
0,47
Shares outstanding
5,10 მლნ.
No. of employees
15
News stories
From web sources and news partners
MarketBeat
MarketBeat
·
8 წუთის წინ
C3.ai (NYSE:AI) Upgraded to "Hold" at Wall Street Zen
Yahoo Finance
Yahoo Finance
·
7 საათის წინ
A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
Seeking Alpha
Seeking Alpha
·
14 საათის წინ
The 1-Minute Market Report October 10, 2026 (NYSEARCA:VOO)
About Mink Therapeutics Inc
CEO-
Employees15
Founded2017
Headquarters-
Sector-
Analyst ratings
Based on 1 analyst giving stock ratings to INKT in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for INKT in the last 3 months
Highest
Current 10,72 US$
35,00 US$ (+226,49%)
Average
35,00 US$ (+226,49%)
Lowest
35,00 US$ (+226,49%)
Analyst
Recommendation
Action
Price target
Projected
Date
Emily Bodnar
H.C. Wainwright
Buy
Reiterated
35,00 US$
+226,5%
08/14/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,14 მლნ.
1,51 მლნ.
1,20 მლნ.
1,89 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,85 მლნ.
1,76 მლნ.
1,68 მლნ.
1,33 მლნ.
Operating expense
3,18 მლნ.
2,71 მლნ.
2,88 მლნ.
3,22 მლნ.
Total operating expenses
3,18 მლნ.
2,71 მლნ.
2,88 მლნ.
3,22 მლნ.
Operating income
-3,18 მლნ.
-2,71 მლნ.
-2,88 მლნ.
-3,22 მლნ.
Other non operating income
240,73 ათ.
-7,87 ათ.
58,58 ათ.
-
EBT including unusual items
-2,89 მლნ.
-2,60 მლნ.
-2,74 მლნ.
-3,13 მლნ.
EBT excluding unusual items
-2,89 მლნ.
-2,60 მლნ.
-2,74 მლნ.
-3,13 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
193,92 ათ.
-571,10 ათ.
-
-
Net income
-2,89 მლნ.
-2,60 მლნ.
-2,74 მლნ.
-3,13 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-0,65
-0,56
-0,57
-0,62
Interest and investment income
55,15 ათ.
111,23 ათ.
80,83 ათ.
72,88 ათ.
Interest expense
-
-
-
-
Net interest expenses
55,15 ათ.
111,23 ათ.
80,83 ათ.
72,88 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-3,14 მლნ.
-2,67 მლნ.
-2,85 მლნ.
-3,18 მლნ.
Gain or loss from assets sale
2,19 ათ.
509,00
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები